Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 146

1.

High Growth Rate of Pancreatic Ductal Adenocarcinoma in CDKN2A-p16-Leiden Mutation Carriers.

Ibrahim IS, Wasser MN, Wu Y, Inderson A, de Vos Tot Nederveen Cappel WH, Morreau H, Hes FJ, Veenendaal RA, Putter H, Feshtali S, van Mil AM, Gruis NA, Tollenaar RA, Bergman W, Bonsing BA, Vasen HFA.

Cancer Prev Res (Phila). 2018 Sep;11(9):551-556. doi: 10.1158/1940-6207.CAPR-18-0035. Epub 2018 Jul 10.

PMID:
29991580
2.

Unscheduled Visits of Patients with Familial Melanoma to a Pigmented Lesion Clinic: Evaluation of Patients' Characteristics and Suspicious Lesions.

Nabil R, Plasmeijer E, van Doorn R, Bergman W, Kukutsch NA.

Acta Derm Venereol. 2018 Jul 11;98(7):667-670. doi: 10.2340/00015555-2922.

3.

Recognizing the haystack is the task of the primary care physician.

Kukutsch NA, Argenziano G, Bergman W.

J Eur Acad Dermatol Venereol. 2018 May;32(5):e190-e191. doi: 10.1111/jdv.14697. Epub 2017 Dec 5. No abstract available.

PMID:
29150885
4.

Germline Variation at CDKN2A and Associations with Nevus Phenotypes among Members of Melanoma Families.

Taylor NJ, Mitra N, Goldstein AM, Tucker MA, Avril MF, Azizi E, Bergman W, Bishop DT, Bressac-de Paillerets B, Bruno W, Calista D, Cannon-Albright LA, Cuellar F, Cust AE, Demenais F, Elder DE, Gerdes AM, Ghiorzo P, Grazziotin TC, Hansson J, Harland M, Hayward NK, Hocevar M, Höiom V, Ingvar C, Landi MT, Landman G, Larre-Borges A, Leachman SA, Mann GJ, Nagore E, Olsson H, Palmer JM, Perić B, Pjanova D, Pritchard A, Puig S, van der Stoep N, Wadt KAW, Whitaker L, Yang XR, Newton Bishop JA, Gruis NA, Kanetsky PA; GenoMEL Study Group.

J Invest Dermatol. 2017 Dec;137(12):2606-2612. doi: 10.1016/j.jid.2017.07.829. Epub 2017 Aug 19.

5.

GNAQ and GNA11 mutations and downstream YAP activation in choroidal nevi.

Vader MJC, Madigan MC, Versluis M, Suleiman HM, Gezgin G, Gruis NA, Out-Luiting JJ, Bergman W, Verdijk RM, Jager MJ, van der Velden PA.

Br J Cancer. 2017 Sep 5;117(6):884-887. doi: 10.1038/bjc.2017.259. Epub 2017 Aug 15.

6.

The opinion of dermoscopy experts about teledermoscopy involving primary care physicians and dermatologists.

Kukutsch NA, Argenziano G, Bergman W.

J Eur Acad Dermatol Venereol. 2017 Oct;31(10):e470-e471. doi: 10.1111/jdv.14259. Epub 2017 May 2. No abstract available.

PMID:
28380269
7.

Conflicting results between the analysis of skin lesions using a mobile-phone application and a dermatologist's clinical diagnosis: a pilot study.

Nabil R, Bergman W, Kukutsch NA.

Br J Dermatol. 2017 Aug;177(2):583-584. doi: 10.1111/bjd.15443. Epub 2017 Jul 4. No abstract available.

PMID:
28295172
8.

Risks of unregulated use of alpha-melanocyte-stimulating hormone analogues: a review.

Habbema L, Halk AB, Neumann M, Bergman W.

Int J Dermatol. 2017 Oct;56(10):975-980. doi: 10.1111/ijd.13585. Epub 2017 Mar 7. Review.

PMID:
28266027
9.

[Recognition and follow-up of the atypical naevus: benign marker or precursor of melanoma?]

Cruz Gómez JM, Bergman W.

Ned Tijdschr Geneeskd. 2016;160:D216. Dutch.

PMID:
27924734
10.

The absence of multiple atypical nevi in germline CDKN2A mutations: Comment on "Hereditary melanoma: Update on syndromes and management: Genetics of familial atypical multiple mole melanoma syndrome".

Ipenburg NA, Gruis NA, Bergman W, van Kester MS.

J Am Acad Dermatol. 2016 Oct;75(4):e157. doi: 10.1016/j.jaad.2016.04.069. No abstract available.

PMID:
27646763
11.

Effect of a Dermoscopy Training Course on the Accuracy of Primary Care Physicians in Diagnosing Pigmented Lesions.

Secker LJ, Buis PA, Bergman W, Kukutsch NA.

Acta Derm Venereol. 2017 Feb 8;97(2):263-265. doi: 10.2340/00015555-2526. No abstract available.

12.

A Female with Hereditary Angioedema Developing Wheals: A Case Report.

van Kester MS, Bergman W, Lavrijsen AP.

Acta Derm Venereol. 2017 Feb 8;97(2):285-286. doi: 10.2340/00015555-2490. No abstract available.

13.

Benefit of Surveillance for Pancreatic Cancer in High-Risk Individuals: Outcome of Long-Term Prospective Follow-Up Studies From Three European Expert Centers.

Vasen H, Ibrahim I, Ponce CG, Slater EP, Matthäi E, Carrato A, Earl J, Robbers K, van Mil AM, Potjer T, Bonsing BA, de Vos Tot Nederveen Cappel WH, Bergman W, Wasser M, Morreau H, Klöppel G, Schicker C, Steinkamp M, Figiel J, Esposito I, Mocci E, Vazquez-Sequeiros E, Sanjuanbenito A, Muñoz-Beltran M, Montans J, Langer P, Fendrich V, Bartsch DK.

J Clin Oncol. 2016 Jun 10;34(17):2010-9. doi: 10.1200/JCO.2015.64.0730. Epub 2016 Apr 25.

PMID:
27114589
14.

Phenotypic and Histopathological Tumor Characteristics According to CDKN2A Mutation Status among Affected Members of Melanoma Families.

Taylor NJ, Handorf EA, Mitra N, Avril MF, Azizi E, Bergman W, Bianchi-Scarrà G, Bishop DT, Bressac-de Paillerets B, Calista D, Cannon-Albright LA, Cuellar F, Cust AE, Demenais F, Elder DE, Friedman E, Gerdes AM, Ghiorzo P, Goldstein AM, Grazziotin TC, Hansson J, Hayward NK, Hocevar M, Höiom V, Holland EA, Ingvar C, Landi MT, Landman G, Larre-Borges A, Leachman SA, Mann GJ, Nagore E, Olsson H, Palmer J, Perić B, Pjanova D, Puig S, Schmid H, van der Stoep N, Tucker MA, Wadt KAW, Whitaker L, Yang XR, Newton Bishop JA, Gruis NA, Kanetsky PA; GenoMEL Consortium.

J Invest Dermatol. 2016 May;136(5):1066-1069. doi: 10.1016/j.jid.2016.01.009. Epub 2016 Jan 28. No abstract available.

15.

The value of clinical characteristics for the diagnosis of melanoma in patients presenting at a pigmented lesion clinic.

Roach RE, Plasmeijer EI, van Doorn R, Bergman W, Kukutsch NA.

Br J Dermatol. 2016 Jun;174(6):1401-3. doi: 10.1111/bjd.14375. Epub 2016 Mar 11. No abstract available.

PMID:
26708210
16.

Total Body Photography as an Aid to Skin Self-examination: A Patient's Perspective.

Secker LJ, Bergman W, Kukutsch NA.

Acta Derm Venereol. 2016 Feb;96(2):186-90. doi: 10.2340/00015555-2228.

17.

Development and validation of a melanoma risk score based on pooled data from 16 case-control studies.

Davies JR, Chang YM, Bishop DT, Armstrong BK, Bataille V, Bergman W, Berwick M, Bracci PM, Elwood JM, Ernstoff MS, Green A, Gruis NA, Holly EA, Ingvar C, Kanetsky PA, Karagas MR, Lee TK, Le Marchand L, Mackie RM, Olsson H, Østerlind A, Rebbeck TR, Reich K, Sasieni P, Siskind V, Swerdlow AJ, Titus L, Zens MS, Ziegler A, Gallagher RP, Barrett JH, Newton-Bishop J.

Cancer Epidemiol Biomarkers Prev. 2015 May;24(5):817-24. doi: 10.1158/1055-9965.EPI-14-1062. Epub 2015 Feb 24.

18.

Prospective risk of cancer and the influence of tobacco use in carriers of the p16-Leiden germline variant.

Potjer TP, Kranenburg HE, Bergman W, de Vos tot Nederveen Cappel WH, van Monsjou HS, Barge-Schaapveld DQ, Vasen HF.

Eur J Hum Genet. 2015 May;23(5):711-4. doi: 10.1038/ejhg.2014.187. Epub 2014 Sep 17.

19.

Cutaneous melanoma: medical specialists' opinions on follow-up and sentinel lymph node biopsy.

Wevers KP, Hoekstra-Weebers JE, Speijers MJ, Bergman W, Gruis NA, Hoekstra HJ.

Eur J Surg Oncol. 2014 Oct;40(10):1276-83. doi: 10.1016/j.ejso.2014.02.240. Epub 2014 Mar 4.

PMID:
24636740
20.

Acquired melanocytic nevi in childhood and familial melanoma.

Vredenborg A, Böhringer S, Boonk SE, Gruis NA, Out-Luijting C, Kukutsch NA, Bergman W.

JAMA Dermatol. 2014 Jan;150(1):35-40. doi: 10.1001/jamadermatol.2013.5588.

PMID:
24196164
21.

Surveillance of second-degree relatives from melanoma families with a CDKN2A germline mutation.

van der Rhee JI, Boonk SE, Putter H, Cannegieter SC, Flinterman LE, Hes FJ, de Snoo FA, Mooi WJ, Gruis NA, Vasen HF, Kukutsch NA, Bergman W.

Cancer Epidemiol Biomarkers Prev. 2013 Oct;22(10):1771-7. doi: 10.1158/1055-9965.EPI-13-0130. Epub 2013 Jul 29.

22.

[Revision of the national guideline 'Melanoma'].

Veerbeek L, Kruit WH, de Wilt J, Mooi WJ, Bergman W; Multidisciplinaire Richtlijnwerkgroep Melanoom.

Ned Tijdschr Geneeskd. 2013;157(12):A6136. Dutch.

PMID:
23515047
23.

A variant in FTO shows association with melanoma risk not due to BMI.

Iles MM, Law MH, Stacey SN, Han J, Fang S, Pfeiffer R, Harland M, Macgregor S, Taylor JC, Aben KK, Akslen LA, Avril MF, Azizi E, Bakker B, Benediktsdottir KR, Bergman W, Scarrà GB, Brown KM, Calista D, Chaudru V, Fargnoli MC, Cust AE, Demenais F, de Waal AC, Dębniak T, Elder DE, Friedman E, Galan P, Ghiorzo P, Gillanders EM, Goldstein AM, Gruis NA, Hansson J, Helsing P, Hočevar M, Höiom V, Hopper JL, Ingvar C, Janssen M, Jenkins MA, Kanetsky PA, Kiemeney LA, Lang J, Lathrop GM, Leachman S, Lee JE, Lubiński J, Mackie RM, Mann GJ, Martin NG, Mayordomo JI, Molven A, Mulder S, Nagore E, Novaković S, Okamoto I, Olafsson JH, Olsson H, Pehamberger H, Peris K, Grasa MP, Planelles D, Puig S, Puig-Butille JA, Randerson-Moor J, Requena C, Rivoltini L, Rodolfo M, Santinami M, Sigurgeirsson B, Snowden H, Song F, Sulem P, Thorisdottir K, Tuominen R, Van Belle P, van der Stoep N, van Rossum MM, Wei Q, Wendt J, Zelenika D, Zhang M, Landi MT, Thorleifsson G, Bishop DT, Amos CI, Hayward NK, Stefansson K, Bishop JA, Barrett JH; GenoMEL Consortium; Q-MEGA and AMFS Investigators.

Nat Genet. 2013 Apr;45(4):428-32, 432e1. doi: 10.1038/ng.2571. Epub 2013 Mar 3.

24.

Genome-wide analysis of gene and protein expression of dysplastic naevus cells.

Gao L, van Nieuwpoort FA, Out-Luiting JJ, Hensbergen PJ, de Snoo FA, Bergman W, van Doorn R, Gruis NA.

J Skin Cancer. 2012;2012:981308. doi: 10.1155/2012/981308. Epub 2012 Nov 28.

25.

Commentary II: The void of congenital naevi.

Bergman W, Meijling KG.

Acta Derm Venereol. 2012 Nov;92(6):586. doi: 10.2340/00015555-1491. No abstract available.

26.

Melanocortin 1 receptor (MC1R) variants in high melanoma risk patients are associated with specific dermoscopic ABCD features.

Quint KD, van der Rhee JI, Gruis NA, Ter Huurne JA, Wolterbeek R, van der Stoep N, Bergman W, Kukutsch NA.

Acta Derm Venereol. 2012 Nov;92(6):587-92. doi: 10.2340/00015555-1457.

27.

Skin examination behavior: the role of melanoma history, skin type, psychosocial factors, and region of residence in determining clinical and self-conducted skin examination.

Kasparian NA, Bränström R, Chang YM, Affleck P, Aspinwall LG, Tibben A, Azizi E, Baron-Epel O, Battistuzzi L, Bruno W, Chan M, Cuellar F, Debniak T, Pjanova D, Ertmanski S, Figl A, Gonzalez M, Hayward NK, Hocevar M, Kanetsky PA, Leachman S, Bergman W, Heisele O, Palmer J, Peric B, Puig S, Schadendorf D, Gruis NA, Newton-Bishop J, Brandberg Y; Melanoma Genetics Consortium (GenoMEL).

Arch Dermatol. 2012 Oct;148(10):1142-51.

28.

Perceptions of genetic research and testing among members of families with an increased risk of malignant melanoma.

Bränström R, Kasparian NA, Affleck P, Tibben A, Chang YM, Azizi E, Baron-Epel O, Bergman W, Chan M, Davies J, Ingvar C, Kanetsky PA, van Leeuwen E, Olsson H, Gruis NA, Brandberg Y, Newton-Bishop J.

Eur J Cancer. 2012 Nov;48(16):3052-62. doi: 10.1016/j.ejca.2012.05.017. Epub 2012 Jun 21.

PMID:
22726816
29.

Genome-wide association study identifies three new melanoma susceptibility loci.

Barrett JH, Iles MM, Harland M, Taylor JC, Aitken JF, Andresen PA, Akslen LA, Armstrong BK, Avril MF, Azizi E, Bakker B, Bergman W, Bianchi-Scarrà G, Bressac-de Paillerets B, Calista D, Cannon-Albright LA, Corda E, Cust AE, Dębniak T, Duffy D, Dunning AM, Easton DF, Friedman E, Galan P, Ghiorzo P, Giles GG, Hansson J, Hocevar M, Höiom V, Hopper JL, Ingvar C, Janssen B, Jenkins MA, Jönsson G, Kefford RF, Landi G, Landi MT, Lang J, Lubiński J, Mackie R, Malvehy J, Martin NG, Molven A, Montgomery GW, van Nieuwpoort FA, Novakovic S, Olsson H, Pastorino L, Puig S, Puig-Butille JA, Randerson-Moor J, Snowden H, Tuominen R, Van Belle P, van der Stoep N, Whiteman DC, Zelenika D, Han J, Fang S, Lee JE, Wei Q, Lathrop GM, Gillanders EM, Brown KM, Goldstein AM, Kanetsky PA, Mann GJ, Macgregor S, Elder DE, Amos CI, Hayward NK, Gruis NA, Demenais F, Bishop JA, Bishop DT; GenoMEL Consortium.

Nat Genet. 2011 Oct 9;43(11):1108-13. doi: 10.1038/ng.959.

30.

Total body skin examination for skin cancer screening in patients with focused symptoms.

Argenziano G, Zalaudek I, Hofmann-Wellenhof R, Bakos RM, Bergman W, Blum A, Broganelli P, Cabo H, Caltagirone F, Catricalà C, Coppini M, Dewes L, Francia MG, Garrone A, Turk BG, Ghigliotti G, Giacomel J, Gourhant JY, Hlavin G, Kukutsch N, Lipari D, Melchionda G, Ozdemir F, Pellacani G, Pellicano R, Puig S, Scalvenzi M, Sortino-Rachou AM, Virgili AR, Kittler H.

J Am Acad Dermatol. 2012 Feb;66(2):212-9. doi: 10.1016/j.jaad.2010.12.039. Epub 2011 Jul 14.

PMID:
21757257
31.

Impact of dermoscopy on the management of high-risk patients from melanoma families: a prospective study.

van der Rhee JI, Bergman W, Kukutsch NA.

Acta Derm Venereol. 2011 Jun;91(4):428-31. doi: 10.2340/00015555-1100.

32.

Clinical and histologic characteristics of malignant melanoma in families with a germline mutation in CDKN2A.

van der Rhee JI, Krijnen P, Gruis NA, de Snoo FA, Vasen HFA, Putter H, Kukutsch NA, Bergman W.

J Am Acad Dermatol. 2011 Aug;65(2):281-288. doi: 10.1016/j.jaad.2010.06.044. Epub 2011 May 12.

PMID:
21570156
33.

Effectiveness and causes for failure of surveillance of CDKN2A-mutated melanoma families.

van der Rhee JI, de Snoo FA, Vasen HFA, Mooi WJ, Putter H, Gruis NA, Kukutsch NA, Bergman W.

J Am Acad Dermatol. 2011 Aug;65(2):289-296. doi: 10.1016/j.jaad.2010.06.067. Epub 2011 May 12.

34.

Magnetic resonance imaging surveillance detects early-stage pancreatic cancer in carriers of a p16-Leiden mutation.

Vasen HF, Wasser M, van Mil A, Tollenaar RA, Konstantinovski M, Gruis NA, Bergman W, Hes FJ, Hommes DW, Offerhaus GJ, Morreau H, Bonsing BA, de Vos tot Nederveen Cappel WH.

Gastroenterology. 2011 Mar;140(3):850-6. doi: 10.1053/j.gastro.2010.11.048. Epub 2010 Dec 1.

PMID:
21129377
35.

A flexible multiplex bead-based assay for detecting germline CDKN2A and CDK4 variants in melanoma-prone kindreds.

Lang JM, Shennan M, Njauw JC, Luo S, Bishop JN, Harland M, Hayward NK, Tucker MA, Goldstein AM, Landi MT, Puig S, Gruis NA, Bergman W, Bianchi-Scarra G, Ghiorzo P, Hogg D, Tsao H.

J Invest Dermatol. 2011 Feb;131(2):480-6. doi: 10.1038/jid.2010.331. Epub 2010 Nov 18.

36.

Association of MC1R variants and host phenotypes with melanoma risk in CDKN2A mutation carriers: a GenoMEL study.

Demenais F, Mohamdi H, Chaudru V, Goldstein AM, Newton Bishop JA, Bishop DT, Kanetsky PA, Hayward NK, Gillanders E, Elder DE, Avril MF, Azizi E, van Belle P, Bergman W, Bianchi-Scarrà G, Bressac-de Paillerets B, Calista D, Carrera C, Hansson J, Harland M, Hogg D, Höiom V, Holland EA, Ingvar C, Landi MT, Lang JM, Mackie RM, Mann GJ, Ming ME, Njauw CJ, Olsson H, Palmer J, Pastorino L, Puig S, Randerson-Moor J, Stark M, Tsao H, Tucker MA, van der Velden P, Yang XR, Gruis N; Melanoma Genetics Consortium.

J Natl Cancer Inst. 2010 Oct 20;102(20):1568-83. doi: 10.1093/jnci/djq363. Epub 2010 Sep 28.

37.

[Mucocutaneous abnormalities in Chlamydia trachomatis-induced reactive arthritis].

Quint KD, van der Helm-van Mil AH, Bergman W, Lavrijsen AP.

Ned Tijdschr Geneeskd. 2010;154:A1614. Review. Dutch.

PMID:
20699017
38.

Predictors of sun protection behaviors and severe sunburn in an international online study.

Bränström R, Kasparian NA, Chang YM, Affleck P, Tibben A, Aspinwall LG, Azizi E, Baron-Epel O, Battistuzzi L, Bergman W, Bruno W, Chan M, Cuellar F, Debniak T, Pjanova D, Ertmanski S, Figl A, Gonzalez M, Hayward NK, Hocevar M, Kanetsky PA, Leachman SA, Heisele O, Palmer J, Peric B, Puig S, Schadendorf D, Gruis NA, Newton-Bishop J, Brandberg Y.

Cancer Epidemiol Biomarkers Prev. 2010 Sep;19(9):2199-210. doi: 10.1158/1055-9965.EPI-10-0196. Epub 2010 Jul 19.

39.

The keratinocyte in epidermal renewal and defence.

Suter MM, Schulze K, Bergman W, Welle M, Roosje P, Müller EJ.

Vet Dermatol. 2009 Oct;20(5-6):515-32. doi: 10.1111/j.1365-3164.2009.00819.x. Review.

PMID:
20178490
40.

[Improved compliance with the 'Melanoma' treatment guideline].

Veerbeek L, van de Poll-Franse LV, Bekkenk MW, Bergman W, Hoekstra HJ, Jansen-Landheer ML, Kruit WH, Mooi WJ, de Vries E, van der Rhee HJ.

Ned Tijdschr Geneeskd. 2010;154:A858. Dutch.

PMID:
20170570
41.

Management of melanoma families.

Bergman W, Gruis NA.

Cancers (Basel). 2010 Apr 16;2(2):549-66. doi: 10.3390/cancers2020549.

42.

Iatrogenic melanoma. Comment on: Melanoma epidemic: a midsummer night's dream?

van der Rhee JI, Mooi WJ, Kukutsch NA, de Snoo FA, Bergman W.

Br J Dermatol. 2010 Feb 1;162(2):457-8. doi: 10.1111/j.1365-2133.2009.09556.x. Epub 2009 Nov 16. No abstract available.

PMID:
19919631
43.

The impact of dermoscopy on the management of pigmented lesions in everyday clinical practice of general dermatologists: a prospective study.

van der Rhee JI, Bergman W, Kukutsch NA.

Br J Dermatol. 2010 Mar;162(3):563-7. doi: 10.1111/j.1365-2133.2009.09551.x. Epub 2009 Oct 15.

PMID:
19832836
44.

Selection criteria for genetic assessment of patients with familial melanoma.

Leachman SA, Carucci J, Kohlmann W, Banks KC, Asgari MM, Bergman W, Bianchi-Scarrà G, Brentnall T, Bressac-de Paillerets B, Bruno W, Curiel-Lewandrowski C, de Snoo FA, Debniak T, Demierre MF, Elder D, Goldstein AM, Grant-Kels J, Halpern AC, Ingvar C, Kefford RF, Lang J, MacKie RM, Mann GJ, Mueller K, Newton-Bishop J, Olsson H, Petersen GM, Puig S, Rigel D, Swetter SM, Tucker MA, Yakobson E, Zitelli JA, Tsao H.

J Am Acad Dermatol. 2009 Oct;61(4):677.e1-14. doi: 10.1016/j.jaad.2009.03.016. Review.

45.

Factors influencing the genesis of neurosurgical technology.

Bergman WC, Schulz RA, Davis DS.

Neurosurg Focus. 2009 Sep;27(3):E3. doi: 10.3171/2009.6.FOCUS09117.

PMID:
19722817
46.

Sun exposure and melanoma risk at different latitudes: a pooled analysis of 5700 cases and 7216 controls.

Chang YM, Barrett JH, Bishop DT, Armstrong BK, Bataille V, Bergman W, Berwick M, Bracci PM, Elwood JM, Ernstoff MS, Gallagher RP, Green AC, Gruis NA, Holly EA, Ingvar C, Kanetsky PA, Karagas MR, Lee TK, Le Marchand L, Mackie RM, Olsson H, Østerlind A, Rebbeck TR, Sasieni P, Siskind V, Swerdlow AJ, Titus-Ernstoff L, Zens MS, Newton-Bishop JA.

Int J Epidemiol. 2009 Jun;38(3):814-30. doi: 10.1093/ije/dyp166. Epub 2009 Apr 8.

47.

Increased risk of cancer other than melanoma in CDKN2A founder mutation (p16-Leiden)-positive melanoma families.

de Snoo FA, Bishop DT, Bergman W, van Leeuwen I, van der Drift C, van Nieuwpoort FA, Out-Luiting CJ, Vasen HF, ter Huurne JA, Frants RR, Willemze R, Breuning MH, Gruis NA.

Clin Cancer Res. 2008 Nov 1;14(21):7151-7. doi: 10.1158/1078-0432.CCR-08-0403.

48.

A pooled analysis of melanocytic nevus phenotype and the risk of cutaneous melanoma at different latitudes.

Chang YM, Newton-Bishop JA, Bishop DT, Armstrong BK, Bataille V, Bergman W, Berwick M, Bracci PM, Elwood JM, Ernstoff MS, Green AC, Gruis NA, Holly EA, Ingvar C, Kanetsky PA, Karagas MR, Le Marchand L, Mackie RM, Olsson H, Østerlind A, Rebbeck TR, Reich K, Sasieni P, Siskind V, Swerdlow AJ, Titus-Ernstoff L, Zens MS, Ziegler A, Barrett JH.

Int J Cancer. 2009 Jan 15;124(2):420-8. doi: 10.1002/ijc.23869.

49.

Genetic testing in familial melanoma: uptake and implications.

de Snoo FA, Riedijk SR, van Mil AM, Bergman W, ter Huurne JA, Timman R, Bertina W, Gruis NA, Vasen HF, van Haeringen A, Breuning MH, Tibben A.

Psychooncology. 2008 Aug;17(8):790-6. doi: 10.1002/pon.1377.

PMID:
18613292
50.

Genome-wide linkage scan for atypical nevi in p16-Leiden melanoma families.

de Snoo FA, Hottenga JJ, Gillanders EM, Sandkuijl LA, Jones MP, Bergman W, van der Drift C, van Leeuwen I, van Mourik L, Huurne JA, Frants RR, Willemze R, Breuning MH, Trent JM, Gruis NA.

Eur J Hum Genet. 2008 Sep;16(9):1135-41. doi: 10.1038/ejhg.2008.72. Epub 2008 Apr 9.

Supplemental Content

Loading ...
Support Center